Jastok

Video-enabled Mobile Calls

Business Software
Private
Follow

Company Overview

Snapshot

Founded in March 2020, Jastok operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its core SaaS system for video-enabled mobile calls.

Business overview

Jastok provides a modular and generic SaaS system designed to transform mobile calls into video sessions without requiring customers to install an app. This technology strengthens customer relationships for organizations like hospitals, control rooms, 24/7 call centers, and customer service centers. The system also features a "Video Call Scheduler" for websites, streamlining appointment setting with relevant representatives. Jastok serves various industries, including healthcare, insurance, and government, operating within the Business Software sector with a focus on Enterprise & Professional Services, Call Centers, and Municipalities.

Log in to access full profile

Company Intelligence Q&A

What is Jastok's primary product?
Jastok offers a modular and generic SaaS system that converts standard mobile calls into video sessions, eliminating the need for customers to download an application. This system enhances customer engagement and operational efficiency for businesses.
Which markets does Jastok primarily serve?
Jastok's solutions are applicable across various markets, including healthcare (hospitals, medical claims), insurance companies, government entities (municipalities), and general enterprise sectors such as call centers and customer service centers. The company has customers in the US and Israel, with pilots underway.
What is the core functionality of Jastok's system?
The core functionality of Jastok's system is to enable video calls from mobile phones without an app, allowing organizations to see a customer's exact location on a map during a call. It also includes a "Video Call Scheduler" for websites, facilitating appointment booking with representatives.
When was Jastok founded?
Jastok was founded in March 2020.
Log in to access full profile